Medtech grants in Israel
Explore Medtech grants for companies in Israel. This list brings together funding for medical devices, diagnostics, digital health and clinical validation from Israeli innovation agencies, research funders and foundations, international programs open to applicants in Israel, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Medtech in Israel come first.
Showing 169-192 of 464 grants
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
NIA · United States
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
SPIE Startup Challenge
SPIE · United States
Pays photonics startups up to $10,000 for pitching live at SPIE Photonics West.
SPIE Startup Challenge
SPIE · United States
Pays up to $10,000 to photonics startups pitching at Photonics West 2027.
SpinLab Accelerator 2027
SpinLab · Germany
Awards up to €50,000 in equity-free funding and mentoring to energy, smart-city and eHealth startups.
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants
NIH · United States
Funds an addition to an existing NIH grant, to take a cancer biomarker assay from working in the lab to working in the clinic.
FARA Clinician Scientist Development Award
FARA · United States
Supports early-career clinician scientists with protected salary time to launch Friedreich's ataxia translational research careers.
FARA General Research Grant
FARA · United States
Funds Friedreich ataxia research on disease mechanisms and translational targets.
FARA Postdoctoral & Graduate Training Awards
FARA · United States
Supports postdoctoral and graduate researchers entering new Friedreich ataxia studies.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
NIH · United States
Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data
NIH · United States
Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds foreign and domestic entities running rare-disease clinical trials through FDA orphan products research grants.
Global Deep Tech Battle @ SLUSH 2026
swisstech · Switzerland
Awards a 3,000-euro cash prize to the winning deep-tech pitch at SLUSH 2026.
Xcelerate Champion of Innovation
WHX Tech · United Arab Emirates
Pays an equity-free cash prize to the top healthcare startup pitching live at WHX Tech's Xcelerate competition in Dubai.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
NIH · United States
Funds a company and an academic group working as one team to turn an imaging, spectroscopy or data-science advance into something usable in the clinic.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
Personal Health Informatics for Delivering Actionable Insights to Individuals
NIH · United States
Funds informatics tools that take a person's own health data and hand back a risk assessment they can understand and do something about.
Translational Neural Devices
NIH · United States
Funds a therapeutic or diagnostic device for the nervous system through prototyping, safety testing, regulatory clearance and a first small clinical study.
CRI Irvington Postdoctoral Fellowship
CRI · United States
Funds three years of stipend support for postdocs training in immunology and cancer research.
High Priority HIV and Substance Use Research (R01)
NIH · United States
Funds research where HIV and drug use intersect. Preliminary data are compulsory, and the work must sit on NIH's published HIV priorities.